Segui
Peter Madrid
Peter Madrid
VP, SRI Biosciences
Email verificata su sri.com
Titolo
Citata da
Citata da
Anno
Evaluation of Ebola virus inhibitors for drug repurposing
PB Madrid, RG Panchal, TK Warren, AC Shurtleff, AN Endsley, CE Green, ...
ACS infectious diseases 1 (7), 317-326, 2015
2732015
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents
PB Madrid, S Chopra, ID Manger, L Gilfillan, TR Keepers, AC Shurtleff, ...
PloS one 8 (4), e60579, 2013
2702013
Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities
PB Madrid, J Sherrill, AP Liou, JL Weisman, JL DeRisi, RK Guy
Bioorganic & medicinal chemistry letters 15 (4), 1015-1018, 2005
1812005
Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum: role of β-haematin …
DC Warhurst, JC Craig, IS Adagu, RK Guy, PB Madrid, QL Fivelman
Biochemical pharmacology 73 (12), 1910-1926, 2007
1212007
Incorporation of an Intramolecular Hydrogen-Bonding Motif in the Side Chain of 4-Aminoquinolines Enhances Activity against Drug-Resistant P. falciparum
PB Madrid, AP Liou, JL DeRisi, RK Guy
Journal of medicinal chemistry 49 (15), 4535-4543, 2006
1112006
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
S Chopra, K Matsuyama, T Tran, JP Malerich, B Wan, SG Franzblau, ...
Journal of antimicrobial chemotherapy 67 (2), 415-421, 2012
1102012
Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum
MO Anderson, J Sherrill, PB Madrid, AP Liou, JL Weisman, JL DeRisi, ...
Bioorganic & medicinal chemistry 14 (2), 334-343, 2006
1062006
The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro
T Lane, M Anantpadma, JS Freundlich, RA Davey, PB Madrid, S Ekins
Pharmaceutical research 36, 1-6, 2019
952019
Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors
PB Madrid, WE Polgar, L Toll, MJ Tanga
Bioorganic & medicinal chemistry letters 17 (11), 3014-3017, 2007
942007
Machine learning models identify molecules active against the Ebola virus in vitro
S Ekins, JS Freundlich, AM Clark, M Anantpadma, RA Davey, P Madrid
F1000Research 4, 2015
902015
Parallel synthesis and antimalarial screening of a 4-aminoquinoline library
PB Madrid, NT Wilson, JL DeRisi, RK Guy
Journal of combinatorial chemistry 6 (3), 437-442, 2004
892004
Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
S Chopra, K Matsuyama, C Hutson, P Madrid
Journal of Antimicrobial Chemotherapy 66 (7), 1533-1536, 2011
862011
Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA
M Mayer, PT Lang, S Gerber, PB Madrid, IG Pinto, RK Guy, TL James
Chemistry & biology 13 (9), 993-1000, 2006
832006
Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2
C Klöck, X Jin, K Choi, C Khosla, PB Madrid, A Spencer, BC Raimundo, ...
Bioorganic & medicinal chemistry letters 21 (9), 2692-2696, 2011
802011
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms
AC Puhl, EJ Fritch, TR Lane, LV Tse, BL Yount, CQ Sacramento, ...
ACS omega 6 (11), 7454-7468, 2021
682021
Efficacy of tilorone dihydrochloride against Ebola virus infection
S Ekins, MA Lingerfelt, JE Comer, AN Freiberg, JC Mirsalis, K O'Loughlin, ...
Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 01711-17, 2018
682018
Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models
S Ray, PB Madrid, P Catz, SE LeValley, MJ Furniss, LL Rausch, RK Guy, ...
Journal of medicinal chemistry 53 (9), 3685-3695, 2010
682010
Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
S Chopra, M Torres-Ortiz, L Hokama, P Madrid, M Tanga, K Mortelmans, ...
Journal of antimicrobial chemotherapy 65 (12), 2598-2601, 2010
652010
SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK)
K Laderoute, JM Calaoagan, PB Madrid, AE Klon, PJ Ehrlich
Cancer biology & therapy 10 (1), 68-76, 2010
622010
Fully automated chemical synthesis: toward the universal synthesizer
N Collins, D Stout, JP Lim, JP Malerich, JD White, PB Madrid, ...
Organic Process Research & Development 24 (10), 2064-2077, 2020
552020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20